← All institutions

Bernstein

218 reports

Reports from this institution

Bernstein

Bernstein: India’s innovative-drug market expands, with GSK and Pfizer offering better growth prospects than Abbott

Bernstein expects demand for chronic-disease and specialty medicines to drive expansion of India’s domestic biopharmaceutical market. In initiating coverage of three listed multinational pharmaceutical companies in India, it names GSK India its top pick; Pfizer first needs to offset the exit of mature products, while Abbott faces a lack of new products and brand competition.

Bernstein

Bernstein: U.S. apparel spending intentions recover, but low-income groups remain cautious

A Bernstein survey shows that respondents across generations are more optimistic about apparel spending in 2027 than a year earlier, but intentions to spend more are concentrated among younger and middle- and higher-income groups. The penetration of off-price retailers among high-income customers has declined, while regular customers are still shopping more frequently.

Bernstein

Bernstein: GE Vernova’s gas-turbine demand floor rises, long-term service revenue becomes key

After discussions with GE Vernova’s management, Bernstein believes the duration of this power cycle matters more than the peak in demand: utility demand and customer advance payments support gas-turbine orders, while new installations could generate service revenue for more than a decade. Electrification growth is constrained by capacity, while wind power still needs to restore profitability.